Kramer, Mark S <br/><br/>
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  Feb 2004 
 - 385-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0893-133X 
<br/><br/><label>Standard No.: </label>10.1038/sj.npp.1300260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antidepressive Agents--therapeutic use<br/>Depressive Disorder, Major--drug therapy<br/>Double-Blind Method<br/>Drug Evaluation<br/>Drug Tolerance<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neurokinin-1 Receptor Antagonists<br/>Personality Inventory<br/>Psychiatric Status Rating Scales<br/>Time Factors<br/>Treatment Outcome